{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Experts who study the effects of synthetic anabolic steroids are encouraged, for two distinctly different reasons, that two new trials of their use show a benefit for two groups of very sick people. One reason is the possible long-term benefits for the patients. But the other is that the trials may serve as a reminder of whom the drugs were not intended for: healthy people who use them in ways that can destroy their health. The trials, reported last week, found that taking anabolic steroids helped kidney dialysis patients and people with H.I.V. regain some of the weight they had been losing uncontrollably as a result of their illnesses.", "headline": {"main": "For the Very Ill, Steroids Can Offer Hope"}, "abstract": "Experts who study effects of synthetic anabolic steroids are encouraged that two new trials of their use show a benefit for two groups of very sick people; trials find that taking anabolic steroids helps kidney dialysis patients and people with HIV regain some of weight they had been losing uncontrollably as result of their illnesses (M)", "print_page": "8", "word_count": 738, "_id": "4fd223d78eb7c8105d7a9e30", "snippet": "Experts who study the effects of synthetic anabolic steroids are encouraged, for two distinctly different reasons, that two new trials of their use show a benefit for two groups of very sick people. One reason is the possible long-term benefits for...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1999/04/20/health/for-the-very-ill-steroids-can-offer-hope.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "WEIGHT"}, {"name": "subject", "value": "DIALYSIS"}, {"name": "subject", "value": "STEROIDS"}, {"name": "subject", "value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME"}, {"name": "subject", "value": "KIDNEYS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By HOLCOMB B. NOBLE"}, "document_type": "article", "pub_date": "1999-04-20T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "In the 14 years since discovering he has Parkinson's disease, Steve Ashworth has slowly lost control of his muscles. Two years ago, with simple tasks like brushing his teeth becoming next to impossible, he eagerly signed up for a chance to stave off his slide into immobility, the first Government-financed study of brain-cell transplants using tissue from aborted fetuses. But the use of fetal cells was not all that made the experiment controversial. Like all 40 people who enrolled, Mr. Ashworth, a 53-year-old labor negotiator for General Motors, would have to undergo brain surgery: four tiny holes drilled into the skull through the wrinkle lines above his eyebrows. Yet only half the participants would get the tissue. The other half would get nothing.", "headline": {"main": "Decisive Moment on Parkinson's Fetal-Cell Transplants"}, "abstract": "Researchers and thousands of patients with Parkinson's disease will soon learn results of study in which tissue from aborted fetuses was transplanted into brains of Parkinson's patients; all 40 people who enrolled in study had four tiny holes drilled into skull, but only half participants got the fetal tissue; as first placebo-controlled, randomized clinical trial using fetal cells for Parkinson's, study is what scientists call 'proof of principle' experiment, one designed to see if treatment has any effect; photo (L)", "print_page": "2", "word_count": 1556, "_id": "4fd1e87d8eb7c8105d736e6d", "snippet": "In the 14 years since discovering he has Parkinson's disease, Steve Ashworth has slowly lost control of his muscles. Two years ago, with simple tasks like brushing his teeth becoming next to impossible, he eagerly signed up for a chance to stave off...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1999/04/20/science/decisive-moment-on-parkinson-s-fetal-cell-transplants.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "BRAIN"}, {"name": "subject", "value": "TRANSPLANTS"}, {"name": "subject", "value": "FETAL TISSUE"}, {"name": "subject", "value": "PLACEBOS"}, {"name": "subject", "value": "PARKINSON'S DISEASE"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "TESTS AND TESTING"}], "byline": {"person": [{"firstname": "Sheryl", "middlename": "Gay", "lastname": "STOLBERG", "rank": 1, "role": "reported", "organization": ""}], "original": "By SHERYL GAY STOLBERG"}, "document_type": "article", "pub_date": "1999-04-20T00:00:00Z", "section_name": "Science; Health"}], "meta": {"hits": 2, "offset": 0, "time": 35}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}